• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    iHuman Inc. Announces Third Quarter 2025 Unaudited Financial Results

    12/29/25 4:11:00 AM ET
    $IH
    Other Consumer Services
    Real Estate
    Get the next $IH alert in real time by email

    BEIJING, Dec. 29, 2025 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the third quarter ended September 30, 2025.

    (PRNewsfoto/iHuman Inc.)

    Third Quarter 2025 Highlights

    • Revenues were RMB205.8 million (US$28.9 million), compared with RMB239.4 million in the same period last year.
    • Gross profit was RMB140.6 million (US$19.8 million), compared with RMB163.9 million in the same period last year.
    • Operating income was RMB16.7 million (US$2.3 million), compared with RMB20.7 million in the same period last year.
    • Net income was RMB21.6 million (US$3.0 million), compared with RMB25.1 million in the same period last year.
    • Average total MAUs[1] for the third quarter were 26.13 million, compared with 29.12 million in the same period last year.

     

    [1] "Average total MAUs" refers to the monthly average of the sum of the MAUs of each of the Company's apps during a specific period, which is counted based on the number of unique mobile devices through which such app is accessed at least once in a given month, and duplicate access to different apps is not eliminated from the total MAUs calculation.

    Dr. Peng Dai, Director and Chief Executive Officer of iHuman, commented, "Despite a complex market environment, we made steady progress this quarter in executing our strategy centered on product innovation and long-term value creation. Over the past few decades, iHuman has earned the trust of millions of families by guiding their children through critical early learning milestones, from recognizing their first Chinese characters to reading their first stories. Building on these strong family connections and our proven leadership in early childhood development, we are now strategically expanding several of our core offerings to serve older age cohorts by leveraging our rich content and technological expertise to address more advanced learning needs. This strategic initiative will deepen our user engagement, broaden our total addressable market, and reinforce the foundation for sustainable, long-term growth.

    Our ongoing commitment to innovation continued to yield significant advancements across our portfolio. In iHuman English, we optimized both interface design and content to deliver a more seamless and inspiring learning journey for young learners. The main world map was redesigned for enhanced clarity and a more intuitive navigation, further improving the learning flow. We also added a curated selection of BBC Studios-licensed kids content, bringing dynamic storytelling, authentic language input, and high-quality visuals that enrich the program and create a compelling learning experience. Combined with interactive tasks and fun speaking prompts thoughtfully designed under our proprietary progressive learning framework, these improvements create a more seamless pathway that encourages deeper engagement and helps children steadily build their English skills and confidence through joyful exploration.

    Complementing our digital products, our smart devices portfolio extends AI-driven learning and companionship deeper into the daily routines of children. We recently launched iHuman AI Pal, our first plush AI companion inspired by our beloved Cosmicrew characters. Designed as a soft, screen-free toy powered by large language model technology, it blends naturally into children's playtime, transforming everyday interactions into opportunities for discovery, imagination, and emotional connection. Beyond simple dialogue, iHuman AI Pal creates an adaptive English and Chinese environment that feels as natural and comforting as talking with a favorite plush friend. Through immersive stories, songs, and interactive fun experiences, it adjusts content to children's respective levels, helping them absorb new expressions effortlessly and build confidence in communication. It also supports holistic growth by fostering positive character, good habits, and safety awareness through memorable, story-based experiences. With built-in long-term memory, it recalls each child's preferences and past interactions, creating a familiar and lasting companionship that encourages open communication and builds confidence. Additionally, a connected mini program for parents keeps the family informed of the child's progress, provides personalized insights, and captures memorable moments — a testament to our vision of responsible, family-centric AI that supports children's development while giving parents peace of mind.

    Following the remarkable success of its inaugural season, our Kunpeng Animation Studio launched the second season of Rainbow Crew in October, adding new depth and creativity to our expanding content library. Since its premiere, the series has consistently ranked among the top children's programs across major streaming platforms, validating its sustained audience appeal. The ongoing success of the Rainbow Crew franchise further strengthens our brand's cultural influence and supports the long-term expansion of our content and licensing portfolio.

    Looking ahead, we will continue to prioritize strategic investment in innovation, technology, and creative excellence to meet the evolving needs of families. With a trusted brand, a loyal user base, and a strong product pipeline, we remain highly confident in our ability to drive strategic progress, deepen our leadership in the children's learning sector, and create lasting value for both users and shareholders."

    Ms. Vivien Weiwei Wang, Director and Chief Financial Officer of iHuman, added, "We are pleased to report our 15th consecutive quarter of profitability, reflecting the solid financial performance and disciplined operational execution that further strengthens our foundation for sustainable growth. At the same time, we continued to expand our market reach by bringing our innovative offerings across a broader range of platforms and everyday lifestyle scenarios. During the quarter, we made meaningful progress in extending our offerings into the smart home ecosystem, with iHuman English now available on multiple leading smart speaker platforms. This expansion brings our content into additional family settings, enabling users to engage with our products more conveniently as part of their everyday home activities. We also expanded into new in-vehicle mobility experiences through cooperation with NIO, a well-recognized smart electric vehicle brand, making our core apps like iHuman Chinese and iHuman Pinyin available within their in-car systems. By expanding beyond traditional learning environments, these partnerships broaden user access to our products and strengthen our influence within the modern family lifestyle."

    Third Quarter 2025 Unaudited Financial Results

    Revenues

    Revenues were RMB205.8 million (US$28.9 million), compared with RMB239.4 million in the same period last year. The decrease in revenues was primarily due to the decline in China's newborn population and more conservative consumer spending.

    Average total MAUs for the quarter were 26.13 million, compared with 29.12 million in the same period last year. The decrease in MAUs was primarily due to the decline in China's newborn population.

    Cost of Revenues

    Cost of revenues was RMB65.1 million (US$9.1 million), compared with RMB75.5 million in the same period last year. The decline in cost of revenues was in line with the decrease in revenues.

    Gross Profit and Gross Margin

    Gross profit was RMB140.6 million (US$19.8 million), compared with RMB163.9 million in the same period last year. Gross margin was 68.3%, compared with 68.4% in the same period last year.

    Operating Expenses

    Total operating expenses were RMB124.0 million (US$17.4 million), a decrease of 13.4% from RMB143.2 million in the same period last year.

    Research and development expenses were RMB55.3 million (US$7.8 million), a decrease of 6.8% from RMB59.3 million in the same period last year, primarily due to savings in payroll-related and outsourcing expenses.

    Sales and marketing expenses were RMB45.7 million (US$6.4 million), a decrease of 24.9% from RMB60.9 million in the same period last year, primarily due to cost savings in marketing activities. 

    General and administrative expenses were RMB22.9 million (US$3.2 million), compared with RMB23.0 million in the same period last year.

    Operating Income

    Operating income was RMB16.7 million (US$2.3 million), compared with RMB20.7 million in the same period last year.

    Net Income

    Net income was RMB21.6 million (US$3.0 million), compared with RMB25.1 million in the same period last year.

    Basic and diluted net income per ADS were RMB0.42 (US$0.06) and RMB0.40 (US$0.06), respectively, compared with RMB0.48 and RMB0.47 in the same period last year. Each ADS represents five Class A ordinary shares of the Company.

    Deferred Revenue and Customer Advances

    Deferred revenue and customer advances were RMB230.4 million (US$32.4 million) as of September 30, 2025, compared with RMB283.3 million as of December 31, 2024.

    Cash, Cash Equivalents and Short-term Investments

    Cash, cash equivalents and short-term investments were RMB1,128.2 million (US$158.5 million) as of September 30, 2025, compared with RMB1,168.7 million as of December 31, 2024.

    Extension of Share Repurchase Program

    Given its confidence in the Company's business prospects, the board of directors (the "Board") has authorized an extension of the Company's existing share repurchase program, as authorized in December 2021 and extended to remain effective to the end of December 2025, by another twelve months through December 31, 2026. Pursuant to the extended share repurchase program, the Company's proposed repurchases may be made from time to time through open market transactions at prevailing market prices, in privately negotiated transactions, in block trades and/or through other legally permissible means, depending on the market conditions and in accordance with applicable rules and regulations. The timing and dollar amount of repurchase transactions will be subject to the Securities and Exchange Commission Rule 10b-18 and Rule 10b5-1 requirements. The Board will continue to review the extended share repurchase program periodically, and may authorize adjustments to its terms and size. The Company expects to continue to fund the repurchases under the extended share repurchase program with its existing cash balance.

    Exchange Rate Information

    The U.S. dollar (US$) amounts disclosed in this press release, except for those transaction amounts that were actually settled in U.S. dollars, are presented solely for the convenience of the reader. The conversion of Renminbi (RMB) into US$ in this press release is based on the exchange rate set forth in the H.10 statistical release of the Board of Governors of the Federal Reserve System as of September 30, 2025, which was RMB7.1190 to US$1.00. The percentages stated in this press release are calculated based on the RMB amounts.

    Non-GAAP Financial Measures

    iHuman considers and uses non-GAAP financial measures, such as adjusted operating income, adjusted net income and adjusted diluted net income per ADS, as supplemental metrics in reviewing and assessing its operating performance and formulating its business plan. The presentation of non-GAAP financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). iHuman defines adjusted operating income, adjusted net income and adjusted diluted net income per ADS as operating income, net income and diluted net income per ADS excluding share-based compensation expenses, respectively. Adjusted operating income, adjusted net income and adjusted diluted net income per ADS enable iHuman's management to assess its operating results without considering the impact of share-based compensation expenses, which are non-cash charges. iHuman believes that these non-GAAP financial measures provide useful information to investors in understanding and evaluating the Company's current operating performance and prospects in the same manner as management does, if they so choose.

    Non-GAAP financial measures are not defined under U.S. GAAP and are not presented in accordance with U.S. GAAP. Non-GAAP financial measures have limitations as analytical tools, which possibly do not reflect all items of expense that affect our operations. Share-based compensation expenses have been and may continue to be incurred in our business and are not reflected in the presentation of the non-GAAP financial measures. In addition, the non-GAAP financial measures iHuman uses may differ from the non-GAAP measures used by other companies, including peer companies, and therefore their comparability may be limited. The presentation of these non-GAAP financial measures is not intended to be considered in isolation from or as a substitute for the financial information prepared and presented in accordance with GAAP.

    Safe Harbor Statement

    This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Statements that are not historical facts, including statements about iHuman's beliefs and expectations, are forward-looking statements. Among other things, the description of the management's quotations in this announcement contains forward-looking statements. iHuman may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the "SEC"), in its annual report to shareholders, in press releases and other written materials, and in oral statements made by its officers, directors or employees to third parties. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: iHuman's growth strategies; its future business development, financial condition and results of operations; its ability to continue to attract and retain users, convert non-paying users into paying users and increase the spending of paying users, the trends in, and size of, the market in which iHuman operates; its expectations regarding demand for, and market acceptance of, its products and services; its expectations regarding its relationships with business partners; general economic and business conditions; regulatory environment; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in iHuman's filings with the SEC. All information provided in this press release is as of the date of this press release, and iHuman does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

    About iHuman Inc.

    iHuman Inc. is a leading provider of tech-powered, intellectual development products in China that is committed to making the child-upbringing experience easier for parents and transforming intellectual development into a fun journey for children. Benefiting from a deep legacy that combines nearly three decades of experience in the parenthood industry, superior original content, advanced high-tech innovation DNA and research & development capabilities with cutting-edge technologies, iHuman empowers parents with tools to make the child-upbringing experience more efficient. iHuman's unique, fun and interactive product offerings stimulate children's natural curiosity and exploration. The Company's comprehensive suite of innovative and high-quality products include self-directed apps, interactive content and smart devices that cover a broad variety of areas to develop children's abilities in speaking, critical thinking, independent reading and creativity. Leveraging advanced technological capabilities, including 3D engines, AI/AR functionality, and big data analysis on children's behavior & psychology, iHuman believes it will continue to provide superior experience that is efficient and relieving for parents, and effective and fun for children, in China and all over the world, through its integrated suite of tech-powered, intellectual development products.

    For more information about iHuman, please visit: https://ir.ihuman.com/

    For investor and media enquiries, please contact:

    iHuman Inc.

    Mr. Justin Zhang

    Investor Relations Director

    Phone: +86-10-5780-6606

    E-mail: [email protected]

    Christensen

    In China

    Ms. Alice Li

    Phone: +86-10-5900-1548

    E-mail: [email protected] 

    In the US

    Ms. Linda Bergkamp

    Phone: +1-480-614-3004

    E-mail: [email protected]

     

     

     

    iHuman Inc.

     

    UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS



    (Amounts in thousands of Renminbi ("RMB") and U.S. dollars ("US$")

    except for number of shares, ADSs, per share and per ADS data)





    December 31,



    September 30,



    September 30,



    2024



    2025



    2025



    RMB



    RMB



    US$













    ASSETS











    Current assets











    Cash and cash equivalents 

    1,123,292



    516,315



    72,526

    Short-term investments

    45,457



    611,844



    85,945

    Accounts receivable, net

    52,030



    64,034



    8,995

    Inventories, net

    23,475



    20,438



    2,871

    Amounts due from related parties

    2,051



    1,674



    235

    Prepayments and other current assets

    89,512



    84,141



    11,819

    Total current assets

    1,335,817



    1,298,446



    182,391

    Non-current assets











    Property and equipment, net

    3,476



    2,375



    334

    Intangible assets, net

    16,429



    16,572



    2,328

    Operating lease right-of-use assets

    14,885



    12,063



    1,694

    Long-term investment

    26,333



    26,333



    3,699

    Other non-current assets

    22,701



    12,196



    1,713

    Total non-current assets

    83,824



    69,539



    9,768

    Total assets

    1,419,641



    1,367,985



    192,159













    LIABILITIES











    Current liabilities











    Accounts payable

    30,233



    27,024



    3,796

    Deferred revenue and customer advances

    283,251



    230,418



    32,367

    Amounts due to related parties

    1,734



    6,499



    913

    Accrued expenses and other current liabilities

    126,501



    109,000



    15,311

    Dividend payable

    2,164



    -



    -

    Current operating lease liabilities

    3,661



    2,166



    304

    Total current liabilities

    447,544



    375,107



    52,691

    Non-current liabilities











    Non-current operating lease liabilities

    11,252



    9,610



    1,350

    Total non-current liabilities

    11,252



    9,610



    1,350

    Total liabilities

    458,796



    384,717



    54,041

    SHAREHOLDERS' EQUITY











    Ordinary shares (par value of US$0.0001 per share,

       700,000,000 Class A shares authorized as of

       December 31, 2024 and September 30, 2025;

       125,122,382 Class A shares issued and 116,084,207

       outstanding as of December 31, 2024; 125,122,382

       Class A shares issued and 111,480,772 outstanding as

       of September 30, 2025; 200,000,000 Class B shares

       authorized, 144,000,000 Class B ordinary shares

       issued and outstanding as of December 31, 2024 and

       September 30, 2025; 100,000,000 shares

       (undesignated) authorized, nil shares (undesignated)

       issued and outstanding as of December 31, 2024 and

       September 30, 2025)

    185



    186



    26

    Additional paid-in capital

    996,657



    960,418



    134,909

    Treasury stock

    (26,296)



    (43,483)



    (6,108)

    Statutory reserves

    8,395



    8,395



    1,179

    Accumulated other comprehensive income

    24,009



    19,865



    2,790

    Retained earnings (accumulated deficit)

    (42,105)



    37,887



    5,322

    Total shareholders' equity

    960,845



    983,268



    138,118

    Total liabilities and shareholders' equity

    1,419,641



    1,367,985



    192,159

     

     

     

    iHuman Inc.

     

    UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS



    (Amounts in thousands of Renminbi ("RMB") and U.S. dollars ("US$")

    except for number of shares, ADSs, per share and per ADS data)











    For the three months ended



    For the nine months ended



    September 30,



    June 30,



    September 30,



    September 30,



    September 30,



    September 30,



    September 30,



    2024



    2025



    2025



    2025



    2024



    2025



    2025



    RMB



    RMB



    RMB



    US$



    RMB



    RMB



    US$





























    Revenues

    239,407



    200,162



    205,764



    28,903



    689,517



    616,365



    86,580

    Cost of revenues

    (75,541)



    (64,414)



    (65,134)



    (9,149)



    (205,805)



    (196,211)



    (27,562)





























    Gross profit

    163,866



    135,748



    140,630



    19,754



    483,712



    420,154



    59,018





























    Operating expenses



























    Research and development expenses

    (59,307)



    (52,834)



    (55,294)



    (7,767)



    (184,449)



    (163,513)



    (22,969)

    Sales and marketing expenses

    (60,863)



    (41,279)



    (45,720)



    (6,422)



    (167,121)



    (128,254)



    (18,016)

    General and administrative expenses

    (22,998)



    (22,146)



    (22,949)



    (3,224)



    (75,148)



    (70,634)



    (9,922)

    Total operating expenses

    (143,168)



    (116,259)



    (123,963)



    (17,413)



    (426,718)



    (362,401)



    (50,907)

    Operating income

    20,698



    19,489



    16,667



    2,341



    56,994



    57,753



    8,111

    Other income, net

    8,024



    14,774



    5,318



    747



    26,444



    28,092



    3,946

    Income before income taxes

    28,722



    34,263



    21,985



    3,088



    83,438



    85,845



    12,057

    Income tax expenses

    (3,579)



    (2,374)



    (400)



    (56)



    (11,330)



    (5,853)



    (822)

    Net income

    25,143



    31,889



    21,585



    3,032



    72,108



    79,992



    11,235





























    Net income per ADS:



























       - Basic

    0.48



    0.62



    0.42



    0.06



    1.37



    1.55



    0.22

       - Diluted

    0.47



    0.60



    0.40



    0.06



    1.33



    1.49



    0.21





























    Weighted average number of ADSs:



























       - Basic

    52,283,334



    51,395,308



    51,201,957



    51,201,957



    52,502,206



    51,492,689



    51,492,689

       - Diluted

    54,011,420



    53,478,410



    53,434,919



    53,434,919



    54,332,011



    53,596,640



    53,596,640





























    Total share-based compensation expenses included in:



























    Cost of revenues

    22



    9



    8



    1



    88



    25



    4

    Research and development expenses

    225



    67



    87



    12



    1,030



    264



    37

    Sales and marketing expenses

    39



    16



    16



    2



    130



    48



    7

    General and administrative expenses

    329



    (5)



    85



    12



    1,022



    184



    26





























     

     

     

    iHuman Inc.

     

    UNAUDITED RECONCILIATION OF GAAP AND NON-GAAP RESULTS



     (Amounts in thousands of Renminbi ("RMB") and U.S. dollars ("US$")

    except for number of shares, ADSs, per share and per ADS data)











    For the three months ended



    For the nine months ended



    September 30,



    June 30,



    September 30,



    September 30,



    September 30,



    September 30,



    September 30,



    2024



    2025



    2025



    2025



    2024



    2025



    2025



    RMB



    RMB



    RMB



    US$



    RMB



    RMB



    US$





























    Operating income

    20,698



    19,489



    16,667



    2,341



    56,994



    57,753



    8,111

    Share-based compensation expenses

    615



    87



    196



    27



    2,270



    521



    74

    Adjusted operating income

    21,313



    19,576



    16,863



    2,368



    59,264



    58,274



    8,185





























    Net income

    25,143



    31,889



    21,585



    3,032



    72,108



    79,992



    11,235

    Share-based compensation expenses

    615



    87



    196



    27



    2,270



    521



    74

    Adjusted net income

    25,758



    31,976



    21,781



    3,059



    74,378



    80,513



    11,309





























    Diluted net income per ADS

    0.47



    0.60



    0.40



    0.06



    1.33



    1.49



    0.21

    Impact of non-GAAP adjustments

    0.01



    0.00



    0.01



    0.00



    0.04



    0.01



    0.00

    Adjusted diluted net income per ADS

    0.48



    0.60



    0.41



    0.06



    1.37



    1.50



    0.21





























    Weighted average number of ADSs – diluted

    54,011,420



    53,478,410



    53,434,919



    53,434,919



    54,332,011



    53,596,640



    53,596,640

    Weighted average number of ADSs – adjusted

    54,011,420



    53,478,410



    53,434,919



    53,434,919



    54,332,011



    53,596,640



    53,596,640

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ihuman-inc-announces-third-quarter-2025-unaudited-financial-results-302650089.html

    SOURCE iHuman Inc.

    Get the next $IH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $IH

    DatePrice TargetRatingAnalyst
    12/30/2022$3.10Buy
    Citigroup
    More analyst ratings

    $IH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    iHuman Inc. Announces Third Quarter 2025 Unaudited Financial Results

    BEIJING, Dec. 29, 2025 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Highlights Revenues were RMB205.8 million (US$28.9 million), compared with RMB239.4 million in the same period last year.Gross profit was RMB140.6 million (US$19.8 million), compared with RMB163.9 million in the same period last year.Operating income was RMB16.7 million (US$2.3 million), compared

    12/29/25 4:11:00 AM ET
    $IH
    Other Consumer Services
    Real Estate

    iHuman Inc. Announces Second Quarter 2025 Unaudited Financial Results

    BEIJING, Sept. 18, 2025 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Highlights Revenues were RMB200.2 million (US$27.9 million), compared with RMB215.1 million in the same period last year.Gross profit was RMB135.7 million (US$19.0 million), compared with RMB151.7 million in the same period last year.Operating income was RMB19.5 million (US$2.7 million), compared wi

    9/18/25 4:30:00 AM ET
    $IH
    Other Consumer Services
    Real Estate

    iHuman and Cricket Media Team Up to Launch Reading Stars

    Reading Stars seamlessly merges Cricket's award-winning content with iHuman's cutting-edge technology, creating an entirely new way for children to engage with reading. BEIJING and MCLEAN, Va., Sept. 18, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH), a leading provider of tech‑powered, intellectual development products in China, and Cricket Media, whose magazines have delighted families for more than 50 years, today announced the global launch of Reading Stars. Drawing on iHuman's expertise in content digitalization, edutainment and interactive learning design, along with Cricket Media's extensive library, the app transforms traditional reading resources into a dynamic digital experience that

    9/18/25 4:00:00 AM ET
    $IH
    Other Consumer Services
    Real Estate

    $IH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Citigroup resumed coverage on iHuman with a new price target

    Citigroup resumed coverage of iHuman with a rating of Buy and set a new price target of $3.10

    12/30/22 8:45:58 AM ET
    $IH
    Other Consumer Services
    Real Estate

    $IH
    SEC Filings

    View All

    SEC Form 6-K filed by iHuman Inc.

    6-K - iHuman Inc. (0001814423) (Filer)

    12/29/25 7:33:02 AM ET
    $IH
    Other Consumer Services
    Real Estate

    SEC Form 6-K filed by iHuman Inc.

    6-K - iHuman Inc. (0001814423) (Filer)

    9/18/25 7:08:02 AM ET
    $IH
    Other Consumer Services
    Real Estate

    SEC Form 6-K filed by iHuman Inc.

    6-K - iHuman Inc. (0001814423) (Filer)

    6/26/25 7:54:57 AM ET
    $IH
    Other Consumer Services
    Real Estate

    $IH
    Financials

    Live finance-specific insights

    View All

    iHuman Inc. Announces Third Quarter 2025 Unaudited Financial Results

    BEIJING, Dec. 29, 2025 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Highlights Revenues were RMB205.8 million (US$28.9 million), compared with RMB239.4 million in the same period last year.Gross profit was RMB140.6 million (US$19.8 million), compared with RMB163.9 million in the same period last year.Operating income was RMB16.7 million (US$2.3 million), compared

    12/29/25 4:11:00 AM ET
    $IH
    Other Consumer Services
    Real Estate

    iHuman Inc. Announces Second Quarter 2025 Unaudited Financial Results

    BEIJING, Sept. 18, 2025 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Highlights Revenues were RMB200.2 million (US$27.9 million), compared with RMB215.1 million in the same period last year.Gross profit was RMB135.7 million (US$19.0 million), compared with RMB151.7 million in the same period last year.Operating income was RMB19.5 million (US$2.7 million), compared wi

    9/18/25 4:30:00 AM ET
    $IH
    Other Consumer Services
    Real Estate

    iHuman Inc. Announces First Quarter 2025 Unaudited Financial Results

    BEIJING, June 26, 2025 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights Revenues were RMB210.4 million (US$29.0 million), compared with RMB235.0 million in the same period last year.Gross profit was RMB143.8 million (US$19.8 million), compared with RMB168.1 million in the same period last year.Operating income was RMB21.6 million (US$3.0 million), compared with

    6/26/25 6:12:00 AM ET
    $IH
    Other Consumer Services
    Real Estate

    $IH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by iHuman Inc. (Amendment)

    SC 13G/A - iHuman Inc. (0001814423) (Subject)

    3/8/22 10:06:04 AM ET
    $IH
    Other Consumer Services
    Real Estate

    SEC Form SC 13G/A filed by iHuman Inc. (Amendment)

    SC 13G/A - iHuman Inc. (0001814423) (Subject)

    2/14/22 4:13:25 PM ET
    $IH
    Other Consumer Services
    Real Estate

    SEC Form SC 13G filed

    SC 13G - iHuman Inc. (0001814423) (Subject)

    2/16/21 6:11:44 AM ET
    $IH
    Other Consumer Services
    Real Estate